Registration - Amendment

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
—

What was lobbied

14 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Manufacturing MAN

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Pharmacy PHA

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Copyright/Patent/Trademark CPT

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Health Issues HCR

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Veterans VET

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Medicare/Medicaid MMM

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Budget/Appropriations BUD

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Chemicals/Chemical Industry CHM

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Animals ANI

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Medical/Disease Research/Clinical Labs MED

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Torts TOR

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Science/Technology SCI

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Advertising ADV

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
SANOFI-AVENTIS SA France France 100.0% —

Affiliated organisations

OrganisationLocation
SANOFI-AVENTIS U.S. LLC Bridgewater, NJ, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.